Chiu, S.K.; Ferrari, E.; Oommen, J.; Malinge, S.; Cheung, L.C.; Kotecha, R.S.
Preclinical Assessment of Dactinomycin in KMT2A-Rearranged Infant Acute Lymphoblastic Leukemia. Cancers 2025, 17, 527.
https://doi.org/10.3390/cancers17030527
AMA Style
Chiu SK, Ferrari E, Oommen J, Malinge S, Cheung LC, Kotecha RS.
Preclinical Assessment of Dactinomycin in KMT2A-Rearranged Infant Acute Lymphoblastic Leukemia. Cancers. 2025; 17(3):527.
https://doi.org/10.3390/cancers17030527
Chicago/Turabian Style
Chiu, Sung K., Emanuela Ferrari, Joyce Oommen, Sebastien Malinge, Laurence C. Cheung, and Rishi S. Kotecha.
2025. "Preclinical Assessment of Dactinomycin in KMT2A-Rearranged Infant Acute Lymphoblastic Leukemia" Cancers 17, no. 3: 527.
https://doi.org/10.3390/cancers17030527
APA Style
Chiu, S. K., Ferrari, E., Oommen, J., Malinge, S., Cheung, L. C., & Kotecha, R. S.
(2025). Preclinical Assessment of Dactinomycin in KMT2A-Rearranged Infant Acute Lymphoblastic Leukemia. Cancers, 17(3), 527.
https://doi.org/10.3390/cancers17030527